GSK's Jideytro (zidesamtinib) gains US approval for previously treated ROS1-positive NSCLC

Kelun-Biotech's Phase III study of sac-TMT in combination with pembrolizumab meets primary endpoint

AstraZeneca signs global licence deal with Dizal for lung cancer drug Zegfrovy

Insilico initiates Rentosertib Phase III clinical trial for idiopathic pulmonary fibrosis

Genentech reports positive Phase III results for divarasib in KRAS G12C lung cancer

Abbisko Therapeutics and AstraZeneca collaborate to conduct combination clinical trial for NSCLC

Co-Diagnostics advances toward FDA filing after completing clinical validation for respiratory point-of-care test

Nuvation Bio's taletrectinib Marketing Authorisation Application for advanced ROS1-positive non-small cell lung cancer treatment validated in UK

Grünenthal completes Nociceptin Receptor (NOP) Agonist Phase I trial

United Therapeutics wins FDA approval for LungFX ex vivo lung perfusion device

bioMérieux files FDA application for rapid vaginitis diagnostic panel

Racura Oncology doses first patient in Phase 1 lung cancer trial

EU approves Cenrifki for secondary progressive multiple sclerosis without relapses

Oxford BioTherapeutics reports progress in Boehringer Ingelheim partnered programmes

Genprex receives Canadian Patent Allowance for Reqorsa gene therapy combination in lung cancer